Isabell Bacot, PA
Medical · Austin, TXNPI 1922234384
Payments from drug & device makers
What this record shows
This record is dominated by education: $43,200 of the $64,903 with a category attached, or 66.6%. Intuitive Surgical accounts for 97.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $16,914 and has fallen 55.7% since, to $7,492 in 2025. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $334.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$63K
- Solventum Corporation$1K
- Davol Inc.$252
- Myriad Genetic Laboratories, Inc.$56
- Heron Therapeutics, Inc.$13
- Endo Pharmaceuticals Inc.$12
What the payments were for
- Travel & lodging$19,96231%
- Food & beverage$1,7423%
- Education$43,20067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 167 | $63,357 |
| Solventum Corporation | 16 | $1,214 |
| Davol Inc. | 5 | $252 |
| Myriad Genetic Laboratories, Inc. | 4 | $56 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$62,254
- ACTIV.A.C.$403
- Bair Hugger$352
- Phasix Mesh$160
How this compares
$64,903 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 46 | $503 |
| Methocarbamol | 25 | $211 |
| Tramadol Hcl | 34 | $124 |
| Gabapentin | 18 | $93 |
Paid to pharmacies, not to this prescriber.
Other medical in Austin
- Lindsay ReckAustin$18K
- Amela PettyAustin$16K
- Jeri BelyeaAustin$14K
- Mikel ZamoraAustin$13K
- Theresa ManriquezAustin$13K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.